The evidence for this drift is economic as much as scientific. Drawing on workforce research by Tadmon and Olfson published in the American Journal of Psychiatry, the authors describe a profession whose practice has narrowed under financial pressure. Psychiatrists increasingly deliver brief medication-management visits rather than the psychotherapy that once defined the field, a shift driven by reimbursement structures, administrative burdens and the economics of outpatient care. Studies from Hughes and colleagues in Psychiatric Services reinforce the picture, documenting how access to psychiatrists providing talk therapy has contracted even as demand for mental health care has surged. The result is a specialty whose self-image, rooted in the integration of biological and psychological treatment, no longer matches the reality of a fifteen-minute medication check.

At the same time, an entirely new therapeutic arsenal has matured. Repetitive transcranial magnetic stimulation, now supported by accelerated protocols that can deliver a full treatment course in days rather than weeks, has moved from experimental novelty to mainstream clinical tool. Esketamine nasal spray and off-label ketamine have introduced rapid-acting pharmacological interventions that require monitored, procedure-like administration. Electroconvulsive therapy, long the most effective treatment for severe depression, continues to evolve with modern techniques such as right unilateral ultrabrief pulse stimulation. Psychedelic-assisted therapies, including psilocybin and MDMA, are advancing through late-stage clinical trials and promise to add further procedurally intensive options. Each of these treatments shares a defining feature: the psychiatrist is no longer simply prescribing a medication, but directly performing or supervising a physical intervention on the brain.

The authors argue that this convergence of forces has created an identity crisis. Professional identity, as the medical education literature from Cruess and colleagues emphasizes, is not a cosmetic matter; it shapes how clinicians see their roles, how trainees choose specialties, how institutions allocate resources and how the public understands what a profession offers. A field that defines itself around diagnostic evaluation and pharmacological management is poorly equipped to steward technologies that require procedural skill, anatomical and neuroscientific knowledge, and rigorous safety protocols. Without a coherent identity, the authors warn, psychiatry risks ceding these interventions to other specialties or to commercial actors operating outside the traditional structures of academic medicine.

Their proposed solution is interventional psychiatry, defined not as a replacement for existing psychiatric practice but as an integrative framework that unites psychiatric judgment with procedural care. The concept is deliberately broad. It encompasses neuromodulation techniques such as TMS, vagus nerve stimulation and deep brain stimulation; pharmacological interventions requiring procedural administration, including ketamine and esketamine; convulsive therapies such as ECT; and, prospectively, psychedelic-assisted treatments. What binds them together is a shared logic: the psychiatrist’s diagnostic acumen, formulation skills and longitudinal therapeutic relationship remain central, but they are now paired with hands-on technical competence and an understanding of circuit-level neuroscience.

To help clinicians and institutions think about this expanding toolkit, the paper introduces a risk–skill matrix, a conceptual map that plots interventions according to the technical skill they demand and the risk they carry to patients. The matrix serves several purposes. It clarifies which treatments can be delivered safely in routine outpatient settings and which require specialized facilities, anesthesia support or intensive monitoring. It provides a rational basis for credentialing and privileging decisions, an increasingly urgent question as TMS clinics proliferate and ketamine administration spreads into commercial practice. And it offers trainees a structured way to understand the competencies they must acquire, from basic certification in office-based neuromodulation to advanced fellowship-level training in interventional procedures.

The historical analogy the authors reach for is cardiology. In 1977, Andreas Grüntzig performed the first coronary angioplasty, an event documented in The Lancet, and in the decades that followed cardiology transformed from a largely diagnostic and pharmacological specialty into one defined by interventional procedures. That transformation did not diminish the cardiologist’s medical judgment; it amplified it, demanding deeper integration of physiology, imaging and procedural technique. The authors contend that psychiatry now stands at a comparable inflection point. Just as interventional cardiology emerged as a recognized identity within cardiology, interventional psychiatry can serve as the organizing concept for a specialty whose therapeutic reach is expanding into direct neural intervention.

The idea itself is not entirely new. As early as 2014, Williams and colleagues argued in the Journal of Clinical Psychiatry and Academic Psychiatry for the development of interventional psychiatry fellowships and training pathways, and subsequent work by Trapp and Williams, along with a 2021 review in the American Journal of Psychiatry led by McIntyre, helped build the scientific case for circuit-based therapeutics in psychiatry. What the new Comment adds is a comprehensive professional framework: a definition, a conceptual structure for classifying interventions, and a roadmap for how training, credentialing and practice organization should evolve. The authors, who span academic centers including Yale, the University of California San Diego, Oxford and Toronto as well as clinical practice, frame the proposal as an evolutionary step rather than a rupture with psychiatric tradition.

The implications for training are among the most concrete. Current residency requirements, governed by the Accreditation Council for Graduate Medical Education, provide limited structured exposure to procedural techniques, and the authors suggest that the field must decide whether interventional competencies should be embedded in core residency training or developed through dedicated fellowships. Either path carries consequences for workforce planning. If interventional psychiatry becomes a recognized subspecialty, it could attract trainees drawn to the technical and neuroscientific dimensions of mental health care, potentially strengthening recruitment into a specialty that has struggled to meet demand. It could also reshape the economics of practice, since procedural services are typically reimbursed differently from brief medication visits, potentially relieving some of the financial pressures that pushed psychotherapy out of psychiatric practice in the first place.

The authors are candid that the framework raises difficult questions. Boundaries must be drawn carefully to avoid implying that interventional techniques should replace psychotherapy or psychosocial care, which remain essential components of treatment for many conditions. Equity of access is a serious concern, since advanced interventions are concentrated in urban and well-resourced settings, and the authors’ own disclosed ties to industry and clinical enterprises underline the commercial stakes involved in how the field develops. Yet their central claim stands on solid ground: the tools of psychiatry have changed faster than its identity, and a profession that treats the brain with electricity, magnetic fields and rapidly acting molecules needs a name and a structure that reflect that reality. Interventional psychiatry, they argue, is that name, and the coming years will determine whether the profession embraces the framework deliberately or continues to evolve by accident.

Subject of Research: A proposed professional framework defining interventional psychiatry amid the growth of procedural mental health treatments

Article Title: Defining interventional psychiatry: a framework for professional identity and practice evolution

Article References: Sauvé, W. M., Insel, T. R., Albright, B. B., Koo, M., Berman, R. M., Stahl, S., Manji, H. K., McIntyre, R. S., & Qian, J. J. (2026). Defining interventional psychiatry: a framework for professional identity and practice evolution. Nature Mental Health. https://doi.org/10.1038/s44220-026-00708-3

Image Credits: AI Generated

DOI: 10.1038/s44220-026-00708-3

Keywords: interventional psychiatry, psychiatry, neuromodulation, transcranial magnetic stimulation, electroconvulsive therapy, ketamine, esketamine, psychedelic therapy, professional identity, medical training, Nature Mental Health, mental health care